Condition
Pulsed-field Ablation
Total Trials
5
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Unknown2
Enrolling By Invitation1
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07752771Not ApplicableCompleted
Durability of Pulmonary Vein Isolation With Farapulse System Using Minimal Fluoroscopy
NCT07633548Enrolling By InvitationPrimary
Safety And FEasibility of a Simplified Deep Sedation Protocol for Pulsed-Field Ablation
NCT05922917Not ApplicableActive Not Recruiting
Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation
NCT06166524Phase 2Unknown
Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation
NCT06096428Unknown
Hemolysis During Pulsed-field and Radiofrequency Ablation
Showing all 5 trials